REGENXBIO’s Headquarters in Rockville, Maryland
3 Ways You Can Navigate Recent Layoffs
Published on :3 Ways You Can Navigate Recent Layoffs By Jennifer Yingling | September 20, 2023 In a media climate where news agencies frequently report on layoffs without delving into what it [….]
Biotech Layoffs Add up to Historic Levels in 2023
Published on :Maryland Biotech Layoffs Add up to Historic Levels in 2023. Here are some resources to help.
Fort Washington-based Nabriva to cut workforce 40%, explore ‘strategic alternatives’
Published on :Montgomery County biopharmaceutical firm reducing workforce by 40% Email Share Share Tweet Share Article Print Order Reprints
Enlarge
The antibiotic Xenleta is one of two products marketed by Fort Washington-based Nabriva.
NABRIVA
IN THIS ARTICLE
Biotech
Topic
Pharmaceuticals
Topic
Merck
Company
Ted Schroeder
Person
By John George – Senior Reporter, Philadelphia Business Journal
Nov 10, 2022
Listen to this article 3 min
Nabriva Therapeutics, a biopharmaceutical company with operations in Fort Washington and Ireland, said Thursday it is reducing its workforce by 40% and pivoting its focus to commercializing its skin and skin structure infections antibiotic while it explores “strategic options” for its future.
The company started the year with 73 employees, 38 of whom work in Montgomery County. The 40% reduction will result in about 29 jobs being eliminated.